These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Randomized comparison of carbon ion-implanted stent versus bare metal stent in coronary artery disease: the Asian Pacific Multicenter Arthos Stent Study (PASS) trial. Kim YH; Lee CW; Hong MK; Park SW; Tahk SJ; Yang JY; Saito S; Santoso T; Quan L; Ge J; Weissman NJ; Lansky AJ; Mintz GS; Park SJ Am Heart J; 2005 Feb; 149(2):336-41. PubMed ID: 15846274 [TBL] [Abstract][Full Text] [Related]
3. Factors predictive of cardiac events and restenosis after sirolimus-eluting stent implantation in small coronary arteries. Lee CW; Suh J; Lee SW; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ Catheter Cardiovasc Interv; 2007 May; 69(6):821-5. PubMed ID: 17191211 [TBL] [Abstract][Full Text] [Related]
4. Study of antirestenosis with the BiodivYsio dexamethasone-eluting stent (STRIDE): a first-in-human multicenter pilot trial. Liu X; Huang Y; Hanet C; Vandormael M; Legrand V; Dens J; Vandenbossche JL; Missault L; Vrints C; De Scheerder I Catheter Cardiovasc Interv; 2003 Oct; 60(2):172-8; discussion 179. PubMed ID: 14517920 [TBL] [Abstract][Full Text] [Related]
5. Influence of stent surface topography on the outcomes of patients undergoing coronary stenting: a randomized double-blind controlled trial. Dibra A; Kastrati A; Mehilli J; Pache J; von Oepen R; Dirschinger J; Schömig A Catheter Cardiovasc Interv; 2005 Jul; 65(3):374-80. PubMed ID: 15926182 [TBL] [Abstract][Full Text] [Related]
6. Percutaneous coronary intervention utilizing a new endothelial progenitor cells antibody-coated stent: a prospective single-center registry in high-risk patients. Miglionico M; Patti G; D'Ambrosio A; Di Sciascio G Catheter Cardiovasc Interv; 2008 Apr; 71(5):600-4. PubMed ID: 18360849 [TBL] [Abstract][Full Text] [Related]
7. Latin American randomized trial of balloon angioplasty versus coronary stenting in diabetic patients with small vessel reference size (Latin American Small Vessel [LASMAL II] Trial): immediate and long-term results. Rodriguez AE; Rodriguez Alemparte M; Fernandez Pereira C; Vigo CF; Sampaolesi A; Bernardi V; Marchand E; Tronge J; Palacios IF; Am Heart J; 2005 Jul; 150(1):188. PubMed ID: 16086559 [TBL] [Abstract][Full Text] [Related]
8. Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts: six-month angiographic, intravascular ultrasound, and clinical follow-up of the RRISC Trial. Vermeersch P; Agostoni P; Verheye S; Van den Heuvel P; Convens C; Bruining N; Van den Branden F; Van Langenhove G J Am Coll Cardiol; 2006 Dec; 48(12):2423-31. PubMed ID: 17174178 [TBL] [Abstract][Full Text] [Related]
9. The new Polish stent Chopin. Assessment of safety and efficacy in the treatment of de-novo coronary lesions using percutaneous angioplasty. Buszman P; Zurakowski A; Kinasz L; Gorycki B; Król M; Lewicki A; Flak Z; Milewski K; Zurek P Kardiol Pol; 2005 May; 62(5):451-9; discussion 460-1. PubMed ID: 15928722 [TBL] [Abstract][Full Text] [Related]
10. Drug-eluting stents in bifurcation lesions: to stent one branch or both? Assali AR; Assa HV; Ben-Dor I; Teplitsky I; Solodky A; Brosh D; Fuchs S; Kornowski R Catheter Cardiovasc Interv; 2006 Dec; 68(6):891-6. PubMed ID: 17086532 [TBL] [Abstract][Full Text] [Related]
11. Comparison of stainless steel stents coated with turbostratic carbon and uncoated stents for percutaneous coronary interventions. Haase J; Störger H; Hofmann M; Schwarz CE; Reinemer H; Schwarz F J Invasive Cardiol; 2003 Oct; 15(10):562-5. PubMed ID: 14519887 [TBL] [Abstract][Full Text] [Related]
13. Stenting alone versus debulking and debulking plus stent in branch ostial lesions of native coronary arteries. Chung CM; Nakamura S; Tanaka K; Tanigawa J; Kitano K; Akiyama T; Matoba Y; Katoh O Heart Vessels; 2004 Sep; 19(5):213-20. PubMed ID: 15372295 [TBL] [Abstract][Full Text] [Related]
14. Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: the diabetes and sirolimus-eluting stent (DIABETES) trial. Sabaté M; Jiménez-Quevedo P; Angiolillo DJ; Gómez-Hospital JA; Alfonso F; Hernández-Antolín R; Goicolea J; Bañuelos C; Escaned J; Moreno R; Fernández C; Fernández-Avilés F; Macaya C; Circulation; 2005 Oct; 112(14):2175-83. PubMed ID: 16203930 [TBL] [Abstract][Full Text] [Related]
15. Outcome in the real-world of coronary high-risk intervention with drug-eluting stents (ORCHID) -- a single-center study comparing Cypher sirolimus-eluting with Taxus paclitaxel-eluting stents. Kumar S; Suresh V; Prendergast BD; Brooks NH; Wicks P; Levy RD; Ray SG; Bennett DH; Lee HS Catheter Cardiovasc Interv; 2006 Nov; 68(5):663-8. PubMed ID: 17034063 [TBL] [Abstract][Full Text] [Related]
16. A comparison of clinical and angiographic outcomes after Excel bioabsorbable polymer versus Firebird durable polymer rapamycin-eluting stent for the treatment of coronary artery disease in a "real world" setting: six-month follow-up results. Liu HB; Xu B; Qiao SB; Yang YJ; Ma WH; Qin XW; Yao M; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Li JJ; Chen JL; Gao RL Chin Med J (Engl); 2007 Apr; 120(7):574-7. PubMed ID: 17442205 [TBL] [Abstract][Full Text] [Related]
17. Firebird and cypher sirolimus-eluting stents and bare metal stents in treatment of very long coronary lesions. Fan L; Chen LL; Lin CG; Peng YF; Zheng XC; Luo YK; Zhang FL; Chen JH; Yan XP; Huang ZR Chin Med J (Engl); 2008 Aug; 121(16):1518-23. PubMed ID: 18982862 [TBL] [Abstract][Full Text] [Related]
18. The Frontier stent registry: safety and feasibility of a novel dedicated stent for the treatment of bifurcation coronary artery lesions. Lefèvre T; Ormiston J; Guagliumi G; Schultheiss HP; Quilliet L; Reimers B; Brunel P; Wijns W; Buettner HJ; Hartmann F; Veldhof S; Miquel K; Su X; van der Giessen WJ J Am Coll Cardiol; 2005 Aug; 46(4):592-8. PubMed ID: 16098421 [TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of the 2.25-mm sirolimus-eluting Bx Velocity stent in the treatment of patients with de novo native coronary artery lesions: the SIRIUS 2.25 trial. Moses JW; Nikolsky E; Mehran R; Cambier PA; Bachinsky WB; Leya F; Kuntz RE; Popma JJ; Schleckser P; Wang H; Cohen SA; Leon MB; Am J Cardiol; 2006 Dec; 98(11):1455-60. PubMed ID: 17126649 [TBL] [Abstract][Full Text] [Related]
20. Optimizing dosimetry with high-dose intracoronary gamma radiation (21 Gy) for patients with diffuse in-stent restenosis. Kuchulakanti P; Torguson R; Canos D; Satler LF; Suddath W; Chan R; White LR; Gevorkian N; Bui A; Wang B; Kent KM; Pichard AD; Waksman R Cardiovasc Revasc Med; 2005; 6(3):108-12. PubMed ID: 16275606 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]